A Comparison of Prophylactic Antibacterial Efficacy of Besivance Versus VIGAMOX Administered for Three Days and One Hour Prior to Phacoemulsification
A Comparison of Prophylactic Antibacterial Efficacy of Besivance Versus VIGAMOX Administered for Three Days and One Hour Prior to Phacoemulsification
To compare antibacterial efficacy of Besivance versus VIGAMOX for decreasing bacteria of the conjunctiva and lid margins in cataract patients prior to surgery after both 1 hour and 3 days of treatment.
Inclusion Criteria:
Exclusion Criteria:
Known allergy or contraindication to the test article(s) or their components.
Presence of any abnormality or significant illness in the eye that in the investigator's opinion could affect the subject's health or the study parameters.
Presence of an active ocular infection (bacterial, viral or fungal), or positive history of ocular herpetic infection.
History of any significant illness that could be expected to interfere with the study parameters. Any condition that, in the opinion of the investigator, would compromise the well-being of the subject or the study.
Use of disallowed therapies (systemic or topical):
Use of contact lenses for one week prior to the study and for the duration of the study.
Received an experimental drug or used an experimental medical device within 21 days before the planned start of treatment.